A prospective Echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: Prevalence and clinical significance

International Journal of General Medicine

Volumn 3, Issue , 2010, Pages 279-286

  Ramasubbu, Kumudha ^a   Deswal, Anita ^a   Herdejurgen, Cheryl ^b   Aguilar, David ^a   Frost, Adaani E ^b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Diastolic dysfunction; Pulmonary hypertension; Renal failure

Indexed keywords

ADULT; ANALYTICAL PARAMETERS; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ETHNICITY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODIALYSIS PATIENT; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; TRICUSPID VALVE REGURGITATION; UNITED STATES;

EID: 79953112306     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Yigla M, Fruchter O, Aharonson D, et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int. 2009;75:969-975.
2. Yigla M, Nakhoul F, Sabag A, et al. Pulmonary hypertension in patients with end-stage renal disease. Chest. 2003;123:1577-1582.
3. Abdelwhab S, Elshinnawy S. Pulmonary hypertension in chronic renal failure patients. Am J Nephrol. 2008;28:990-997.
4. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN. Abnormalities of endothelial function in patients with predialysis renal failure. Heart. 2000;83:205-209.
5. Morris CR, Gladwin MT, Kato GJ. Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders. Curr Mol Med. 2008;8:620-632.
6. Okura H, Takatsu Y. High-output heart failure as a cause of pulmonary hypertension. Intern Med. 1994;33:363-365.
7. Barak M, Katz Y. Microbubbles: pathophysiology and clinical implications. Chest. 2005;128:2918-2932.
8. Fathi R, Isbel N, Haluska B, Case C, Johnson DW, Marwick TH. Correlates of subclinical left ventricular dysfunction in ESRD. Am J Kidney Dis. 2003;41:1016-1025.
9. USRDS 2008 Annual Data Report [report on the Internet]. United States Renal Data System. Available from: www.usrds.org/adr.htm. 2009.
10. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15:167-184.
11. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18: 1440-1463.
12. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009;22:107-133.
13. Horton KD, Meece RW, Hill JC. Assessment of the right ventricle by echocardiography: a primer for cardiac sonographers. J Am Soc Echocardiogr. 2009;22:776-792.
14. Havlucu Y, Kursat S, Ekmekci C, et al. Pulmonary hypertension in patients with chronic renal failure. Respiration. 2007;74:503-510.
15. Barberato SH, Pecoits-Filho R. Usefulness of left atrial volume for the differentiation of normal from pseudonormal diastolic function pattern in patients on hemodialysis. J Am Soc Echocardiogr. 2007;20: 359-365.
16. Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant. 1990;5:39-44.
17. Mall G, Rambausek M, Neumeister A, Kollmar S, Vetterlein F, Ritz E. Myocardial interstitial fibrosis in experimental uremia - implications for cardiac compliance. Kidney Int. 1988;33:804-811.
18. London GM, Parfrey PS. Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther. 1997;4:194-211.
19. London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant. 2002;17 Suppl 1:29-36.
20. Amin M, Fawzy A, Hamid MA, Elhendy A. Pulmonary hypertension in patients with chronic renal failure: role of parathyroid hormone and pulmonary artery calcifications. Chest. 2003;124:2093-2097.
21. Mahdavi-Mazdeh M, Alijavad-Mousavi S, Yahyazadeh H, Azadi M, Yoosefnejad H, Ataiipoor Y. Pulmonary hypertension in hemodialysis patients. Saudi J Kidney Dis Transpl. 2008;19:189-193.
22. Tarrass F, Benjelloun M, Medkouri G, Hachim K, Benghanem MG, Ramdani B. Doppler echocardiograph evaluation of pulmonary hypertension in patients undergoing hemodialysis. Hemodial Int. 2006;10:356-359.
23. Yigla M, Fruchter O, Aharonson D, et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int. 2009;75:969-975.